Polyamine content of Pneumocystis carinii and response to the ornithine decarboxylase inhibitor DL-alpha-difluoromethylornithine

被引:28
作者
Merali, S [1 ]
Clarkson, AB [1 ]
机构
[1] NYU,SCH MED,DEPT MED & MOLEC PARASITOL,NEW YORK,NY 10016
关键词
D O I
10.1128/AAC.40.4.973
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Difluoromethylornithine (DFMO; eflornithine hydrochloride [Ornidyl]), a suicide inhibitor of the key polyamine biosynthesis enzyme ornithine decarboxylase (ODC), is effective in treating Pneumocystis carinii pneumonia, a common opportunistic infection associated with AIDS, Despite DFMO's specificity for ODC, the reason for its selective toxicity against P. carinii is unknown since both host and parasite are dependent on the same enzyme for polyamine biosynthesis, A new high-performance liquid chromatography method was used with P. carinii cells isolated from infected rat lungs to measure polyamine content, to confirm the presence of ODC, and to examine the effect of DFMO on polyamine concentrations, Putrescine, spermidine, and spermine were found to be present at 2.00 +/- 0.54, 1.26 +/- 0.51, and 1.59 +/- 0.91 nmol (mg of protein)(-1), respectively, neither unusually high nor low values, ODC's specific activity was 79 +/- 11 pmol (mg of protein)(-1) h(-1), again not a remarkable value, However, the rates of both DFMO-induced polyamine depletion and subsequent repletion upon DFMO removal were unusually high, A 3-h exposure to 1 mM DFMO in vitro caused the depletion of putrescine, spermidine, and spermine to levels 12, 29, and 16%, respectively, of that of control cells, After DFMO removal and incubation for 1 h in serum-free media, polyamine levels returned to 78, 88, and 64%, respectively, of that of the control cells not exposed to DFMO, Since such depletions and repletions usually occur over periods of days rather than hours, these rapid changes may provide a clue to the selective action of DFMO against P. carinii and may guide the development of new compounds and an optimal drug administration schedule for DFMO.
引用
收藏
页码:973 / 978
页数:6
相关论文
共 43 条
  • [11] RECENT ADVANCES IN THE DIAGNOSIS, TREATMENT, AND PREVENTION OF PNEUMOCYSTIS-CARINII PNEUMONIA
    DAVEY, RT
    MASUR, H
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (04) : 499 - 504
  • [12] RESTORATION OF THE POLYAMINE CONTENTS IN RAT HEPATOMA TISSUE-CULTURE CELLS AFTER INHIBITION OF POLYAMINE BIOSYNTHESIS - RELATIONSHIP WITH CELL-PROLIFERATION
    GERNER, EW
    MAMONT, PS
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1986, 156 (01): : 31 - 35
  • [13] POLYAMINE DEPLETION FOLLOWING EXPOSURE TO DL-ALPHA-DIFLUOROMETHYLORNITHINE BOTH INVIVO AND INVITRO INITIATES MORPHOLOGICAL ALTERATIONS AND MITOCHONDRIAL ACTIVATION IN A MONOMORPHIC STRAIN OF TRYPANOSOMA-BRUCEI-BRUCEI
    GIFFIN, BF
    MCCANN, PP
    BITONTI, AJ
    BACCHI, CJ
    [J]. JOURNAL OF PROTOZOOLOGY, 1986, 33 (02): : 238 - 243
  • [14] GOLDEN JA, 1984, WESTERN J MED, V141, P613
  • [15] GRIFFIN CA, 1987, INVEST NEW DRUG, V5, P177
  • [16] GROSSIE VB, 1987, CANCER RES, V47, P1836
  • [17] HOLTTA E, 1973, BIOCHEM J, V136, P669
  • [18] EFFICACY OF DIAMINODIPHENYLSULFONE AND OTHER DRUGS IN MURINE PNEUMOCYSTIS-CARINII PNEUMONITIS
    HUGHES, WT
    SMITH, BL
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (04) : 436 - 440
  • [19] PNEUMOCYSTIS-CARINII PNEUMONIA - A COMPARISON BETWEEN PATIENTS WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME AND PATIENTS WITH OTHER IMMUNODEFICIENCIES
    KOVACS, JA
    HIEMENZ, JW
    MACHER, AM
    STOVER, D
    MURRAY, HW
    SHELHAMER, J
    LANE, HC
    URMACHER, C
    HONIG, C
    LONGO, DL
    PARKER, MM
    NATANSON, C
    PARRILLO, JE
    FAUCI, AS
    PIZZO, PA
    MASUR, H
    [J]. ANNALS OF INTERNAL MEDICINE, 1984, 100 (05) : 663 - 671
  • [20] POLYAMINE METABOLISM IN PNEUMOCYSTIS-CARINII
    LIPSCHIK, GY
    MASUR, H
    KOVACS, JA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (05) : 1121 - 1127